Med-Chemist : "Quintessential Medicinal Chemistry"
Thursday, August 4, 2016
New triple drug combination shows promise in hepatitis C infected patients: High sustained virologic response achieved with sofosbuvir/velpatasvir and GS-9857, even in patients unsuccessfuly treated with direct-acting antivirals
›
New data presented today at The International Liver Congress™ 2016 in Barcelona, Spain, demonstrates a high sustained virologic response (...
Wednesday, August 3, 2016
Experimental drug guadecitabine found safe in patients with colorectal cancer: Combination with standard chemotherapy shows promise in overcoming treatment resistance
›
In continuation of my update on guadecitabine (SGI-110) In a small, phase I clinical trial, Johns Hopkins Kimmel Cancer Center re...
Tuesday, August 2, 2016
Study demonstrates therapeutic potential of SOD-mimetic compound M40403 against Parkinson disease
›
Parkinson disease is a debilitating and incurable neurodegenerative disorder, affecting approximately 1-2% of people over sixty-five years...
Monday, August 1, 2016
Cyclodextrin dissolves cholesterol crystals, reduces atherosclerotic plaques
›
In continuation of my update of cyclodextrin Cardiovascular disease from atherosclerosis is one of the most common causes of de...
Saturday, July 30, 2016
Valeant and Progenics Announce FDA Approves Relistor Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain
›
In continuation of my update on Naltrexone Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announ...
Friday, July 29, 2016
Added benefit of crizotinib drug for first-line treatment of advanced bronchial carcinoma not proven
›
In continuation of my update on crizotinib The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients...
Thursday, July 28, 2016
Zonisamide relieves myoclonus dystonia motor symptoms
›
A randomised crossover trial shows that zonisamide significantly improves motor symptoms and related disability in adults with myoclonus ...
Wednesday, July 27, 2016
Common antihistamine may partially reverse damage to visual system in multiple sclerosis patients
›
A common antihistamine used to treat symptoms of allergies and the common cold, called clemastine fumarate, partially reversed damage to t...
Tuesday, July 26, 2016
Anti-inflammatory drugs may improve severity of depressive symptoms, study finds
›
Anti-inflammatory drugs similar to those used to treat conditions such as rheumatoid arthritis and psoriasis could in future be used to tr...
Daily dose of coffee could help reverse non-alcoholic fatty liver disease
›
Adding coffee to the diet of people with non-alcoholic fatty liver disease (NAFLD) could help reverse the condition, according to a new st...
Monday, July 25, 2016
Willow herb extracts may be beneficial in treating multi-drug resistant bacterial and fungal infections
›
A common herb, Epilobi Hirsuti (see pic) could help reduce antibiotic doses and result in less severe side effects in treatments aga...
Friday, July 22, 2016
Intestinal bacteria can be used to reduce cancer risk, reveals UCLA study
›
Researchers have shown that various types of intestinal bacteria might be factors in both causing and preventing obesity, and in other con...
Thursday, July 21, 2016
New oral blood thinners can decrease stroke risk in atrial fibrillation patients without frequent monitoring
›
In continuation of my update on dabigatran (Pradaxa) , rivaroxaban (Xarelto) , apixaban (Eliquis) and edoxaban (Savaysa) . A new g...
Wednesday, July 20, 2016
Cholesterol-fighting drug molecule can kill prostate cancer cells
›
(Ro 48-8071 fumarate) [4′-[6-(Allylmethylamino)hexyloxy]-4-bromo-2′-fluorobenzophenone fumarate Standard treatment for prost...
‹
›
Home
View web version